Status:

RECRUITING

Chlorhexidine Lavage for Recurrent Urinary Tract Infection

Lead Sponsor:

Oregon Health and Science University

Conditions:

Urinary Tract Infections

Recurrent Urinary Tract Infection

Eligibility:

FEMALE

55-89 years

Phase:

PHASE4

Brief Summary

A two-arm randomized control trial evaluating rates of urinary tract infection in post-menopausal women on vaginal estrogen with recurrent urinary tract infections.

Detailed Description

There is a critical need for low-cost, non-antibiotic interventions that are feasible for patients to utilize for risk reduction and prevention of recurrent urinary tract infections (UTIs). The curren...

Eligibility Criteria

Inclusion

  • Post-menopausal female between age 55 and 89
  • No post-menopausal bleeding
  • Diagnosis of recurrent urinary tract infection (UTI) in the electronic health record or as two culture proven UTIs in 6 months or three culture proven UTIs in 12 months
  • At least one UTI in the 6 months prior to entering the study
  • Asymptomatic for UTI symptoms at the time of enrollment.
  • On vaginal estrogen therapy for at least 6 weeks prior to enrollment
  • Ready access to email and internet

Exclusion

  • Recent prophylactic antibiotic use (washout period of 4 weeks)
  • Neurogenic bladder
  • Diagnosis of urinary retention
  • Uncorrected Stage III-IV prolapse
  • Indwelling catheter or need for intermittent self-catheterization
  • History of complicated UTIs
  • History of interstitial cystitis or bladder pain syndrome
  • History of fecal incontinence/accidental bowel leakage
  • Greater than 14 bowel movements per week
  • Non-English speaking
  • Allergy to chlorhexidine gluconate
  • Inability to utilize vaginal estrogen therapy
  • Recent urogynecological or urologic surgery (\<12 weeks)

Key Trial Info

Start Date :

December 23 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2026

Estimated Enrollment :

136 Patients enrolled

Trial Details

Trial ID

NCT06598514

Start Date

December 23 2024

End Date

June 1 2026

Last Update

March 24 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Oregon Health & Science University

Portland, Oregon, United States, 97239